Deciphera Pharmaceuticals, Inc. Cash and Cash Equivalents
Deciphera Pharmaceuticals, Inc. had Cash and Cash Equivalents of $91.23 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-05-10
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $91.23M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $83.51M.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $108.09M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $81.39M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-03-31 | $91.23M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $83.51M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $108.09M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $81.39M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $114.64M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $64.74M 10-K · filed 2024-02-07 |
| 2022-09-30 | $82.54M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $109.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $95.33M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $87.06M 10-K · filed 2023-02-07 |
| 2021-09-30 | $53.19M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $90.95M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $201.65M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $135.90M 10-K · filed 2022-02-08 |
| 2020-09-30 | $111.15M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $155.45M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $229.65M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $120.32M 10-K · filed 2021-02-09 |
| 2019-09-30 | $173.71M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $57.24M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $82.23M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $293.76M 10-K · filed 2020-03-09 |
| 2018-09-30 | $320.88M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $346.53M 10-Q · filed 2019-08-02 |
| 2018-03-31 | $179.87M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $196.75M 10-Q · filed 2019-08-02 |
| 2017-03-31 | $49.96M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $57.46M 10-K · filed 2019-03-14 |
| 2015-12-31 | $25.78M 10-K · filed 2019-03-14 |
| 2014-12-31 | $770.00K 10-K · filed 2018-03-28 |